RecruitingNot Applicable

Individualized ANH for Non-cardiac Surgery

China40 participantsStarted 2024-06-01

Plain-language summary

In this trial, we proposed an individualized acute normovolemic hemodilution (ANH), and conduct a randomized controlled trial to testify the effect of individualized ANH on red cells requirement for non-cardiac surgeries with anticipating major blood loss in adults.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients undergoing elective non-cardiac surgery with an anticipated red blood cells transfusion \>8 units (or 1600ml) * Aged 18\~75 years * Preoperative Hb level \> 120g/L for men and \> 110g/L for women. Exclusion Criteria: * Refusal of blood transfusion * Cardiopulmonary insufficiency * Cerebrovascular disease * Renal impairment * Hemoglobinopathies or blood system diseases * Other situations not suitable for inclusion in clinical trial.

What they're measuring

ABT requirement

Timeframe: Up to 12 weeks.

Trial details

NCT IDNCT06399536

SponsorWest China Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-31

Contact for this trial

Ren Liao, M.D.

+86-18980602177 liaoren7733@163.com

View on ClinicalTrials.gov More Transfusion Related Complication trials